Literature DB >> 3013876

Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells.

S T Sawyer, S B Krantz.   

Abstract

Erythropoietin (EP) responsive Friend virus-infected erythroid cells had 200,000 steady-state binding sites for transferrin at 37 degrees C when isolated from the spleens of Friend virus-infected mice. Upon culture of these cells with EP, the synthesis of transferrin receptors increased 4- to 7-fold and the number of transferrin-binding sites per cell doubled after 24 h. However, the rate of uptake of 59Fe from transferrin remained constant at approximately 35,000 atoms of 59Fe per minute per cell during this period in culture. The amount of 125I-transferrin internalized during the steady-state binding did not change during this culture period while the transferrin bound to the surface increased 3-fold. At all stages of erythroid maturation, the maximum rate of endocytosis was determined to be 18,000 molecules of transferrin per minute per cell, and the interval that 125I-transferrin remains in the interior of the cell was calculated to be 6.9 min. After 48 h of culture with EP, the number of steady-state transferrin-binding sites was reduced in part due to the sequestration of surface receptors within the cell. The uptake of iron from transferrin was limited by the level of endocytosis of transferrin during the initial phase of culture and the number of transferrin receptors at the cell surface during the latter stages of erythroid maturation of these cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013876

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis.

Authors:  Ke Chen; Jing Liu; Susanne Heck; Joel A Chasis; Xiuli An; Narla Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

Review 2.  Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

3.  Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.

Authors:  Arienne Mirmiran; Caroline Schmitt; Thibaud Lefebvre; Hana Manceau; Raêd Daher; Vincent Oustric; Antoine Poli; Jean-Jacques Lacapère; Boualem Moulouel; Hervé Puy; Zoubida Karim; Katell Peoc'h; Hugo Lenglet; Sylvie Simonin; Jean-Charles Deybach; Gaël Nicolas; Laurent Gouya
Journal:  Am J Hum Genet       Date:  2019-01-31       Impact factor: 11.025

4.  The effect of lead on iron uptake from transferrin in human erythroleukemia (K562) cells.

Authors:  H Kohno; S Taketani; R Tokunaga
Journal:  Biometals       Date:  1993       Impact factor: 2.949

5.  Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells.

Authors:  S T Sawyer; S B Krantz; J Luna
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 6.  Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells.

Authors:  Julie A Gaasch; Paul R Lockman; Werner J Geldenhuys; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

7.  Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells.

Authors:  J R Wright; J D Borchelt; S Hawgood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles.

Authors:  Chung Hang J Choi; Christopher A Alabi; Paul Webster; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

9.  Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.

Authors:  G Vreugdenhil; B Manger; C Nieuwenhuizen; R A Feelders; H G van Eijk; A J Swaak
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

10.  Transferrin microheterogeneity in rheumatoid arthritis. Relation with disease activity and anemia of chronic disease.

Authors:  R A Feelders; G Vreugdenhil; G de Jong; A J Swaak; H G van Eijk
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.